Frequency (n) and percentage of comorbidities in AYA HOPE participants, by comorbidity index
| Comorbidity index | |||
|---|---|---|---|
| AYA HOPE | Charlson | NCI | |
| n (%) | n (%) | n (%) | |
| Comorbidity categories | |||
| Cardiovascular | 30 (6.2) | 12 (2.5) | b |
| Diabetes | 18 (3.7) | 18 (3.7) | 18 (3.7) |
| Endocrine | 10 (2.1) | b | a |
| Gastrointestinal | 20 (4.1) | 6 (1.2) | 5 (1.0) |
| HIV/AIDS | 18 (3.7) | 18 (3.7) | 18 (3.7) |
| Hypertension | 29 (6.0) | 29 (6.0) | a |
| Liver | 13 (2.7) | 13 (2.7) | 13 (2.7) |
| Mental health | 40 (8.2) | a | a |
| Neurologic | 42 (8.7) | b | b |
| Obesity/overweight | 28 (5.8) | a | a |
| Renal | 5 (1.0) | b | b |
| Asthma/respiratory | 30 (6.1) | 30 (6.1) | 30 (6.1) |
| Rhematologic/autoimmune | 5 (1.0) | 5 (1.0) | 5 (1.0) |
| Hematologic | b | a | a |
| Distribution of number of comorbidities | |||
| 0 | 320 (66.4) | 381 (78.6) | 406 (83.7) |
| 1 | 94 (19.4) | 80 (16.5) | 66 (13.6) |
| ≥2 | 71 (14.6) | 24 (4.9) | 13 (2.7) |